ORBIMED ADVISORS LLC - 30 Sep 2025 SCHEDULE 13G/A Report for RAPT Therapeutics, Inc. Common Stock, par value $0.0001 per share (RAPT)

Filing Manager: ORBIMED ADVISORS LLC
Reporting Manager: ORBIMED ADVISORS LLC
Security: RAPT Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: RAPT
Shares outstanding: 16,463,909 shares
Disclosed Ownership: 1,086,618 shares
Ownership: 6.6%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 18:18:35 UTC
Date of event: 30 Sep 2025
Previous filing: 14 Feb 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIMED ADVISORS LLC	6.6%	1,086,618	0	1,086,618	/s/ Carl L. Gordon	Carl L. Gordon/Member